ATE318893T1 - Verbesserte replikation von hcv rna - Google Patents

Verbesserte replikation von hcv rna

Info

Publication number
ATE318893T1
ATE318893T1 AT01956106T AT01956106T ATE318893T1 AT E318893 T1 ATE318893 T1 AT E318893T1 AT 01956106 T AT01956106 T AT 01956106T AT 01956106 T AT01956106 T AT 01956106T AT E318893 T1 ATE318893 T1 AT E318893T1
Authority
AT
Austria
Prior art keywords
hcv rna
provides methods
improved replication
cells
sub
Prior art date
Application number
AT01956106T
Other languages
English (en)
Inventor
Hui-Hua Lu
Mark Selby
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of ATE318893T1 publication Critical patent/ATE318893T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/69—Increasing the copy number of the vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT01956106T 2000-08-04 2001-08-03 Verbesserte replikation von hcv rna ATE318893T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22324400P 2000-08-04 2000-08-04

Publications (1)

Publication Number Publication Date
ATE318893T1 true ATE318893T1 (de) 2006-03-15

Family

ID=22835673

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01956106T ATE318893T1 (de) 2000-08-04 2001-08-03 Verbesserte replikation von hcv rna

Country Status (7)

Country Link
US (2) US6660471B2 (de)
EP (1) EP1320583B1 (de)
AT (1) ATE318893T1 (de)
AU (1) AU2001278139A1 (de)
CA (1) CA2416633C (de)
DE (1) DE60117561T2 (de)
WO (1) WO2002012477A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002059321A2 (en) * 2001-01-23 2002-08-01 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa Hepatitis c virus replicons and replicon enhanced cells
EP1490389A4 (de) * 2002-04-03 2006-08-09 Smithkline Beecham Corp Subgenomische replicons des hepatitis-c-virus
EP2611463A2 (de) 2010-09-03 2013-07-10 Stem Centrx, Inc. Identifzierung und anreicherung von zellsubpopulationen
US9778264B2 (en) 2010-09-03 2017-10-03 Abbvie Stemcentrx Llc Identification and enrichment of cell subpopulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840565A (en) * 1995-08-22 1998-11-24 The Regents Of The University Of California Methods for enhancing the production of viral vaccines in PKR-deficient cell culture
US6740519B1 (en) * 1997-11-03 2004-05-25 Mount Sinai School Of Medicine Immortalized, homozygous stat1-deficient mammalian cell lines and their uses

Also Published As

Publication number Publication date
EP1320583A2 (de) 2003-06-25
US7183107B2 (en) 2007-02-27
CA2416633A1 (en) 2002-02-14
US20040076612A1 (en) 2004-04-22
CA2416633C (en) 2013-04-30
EP1320583B1 (de) 2006-03-01
WO2002012477A3 (en) 2003-04-10
DE60117561T2 (de) 2007-01-11
US6660471B2 (en) 2003-12-09
AU2001278139A1 (en) 2002-02-18
WO2002012477A2 (en) 2002-02-14
US20020142455A1 (en) 2002-10-03
DE60117561D1 (de) 2006-04-27

Similar Documents

Publication Publication Date Title
ATE472335T1 (de) Chimere alphavirus-replikon-partikel
NO20091761L (no) Viruskapsomervaksine, fremgangsmate for fremstilling samt anvendelse derav
DE69942708D1 (de) Virus enthaltende Zusammensetzungen und Methoden zur Konzentration von Viruspräparaten
EP1381280A4 (de) Virusvektoren und ihre verwendung bei therapeutischen methoden
ATE466932T1 (de) Vermehrung von viren in zellkultur
EA200900288A1 (ru) Вакцина
NI200800114A (es) Compuestos y métodos para inhibir la replicación viral de hepatitis c
HUP0302957A2 (hu) Hepatitis C vírus alkil- és aril-alanin P2 csoportokat tartalmazó makrociklusos NS-3 szerin proteáz inhibitorai
PL371736A1 (en) Method for administering glp-1 molecules
CY1109012T1 (el) Παραγωγα νουκλεοσιδιου σαν αναστολεις της rna-εξαρτωμενης rna iϊκης πολυμepασης
ATE327246T1 (de) Hepatitis c tripeptid inhibitoren
DK1387681T3 (da) Anvendelse af castanosperinderivater til behandling af hepatitis C
EA200001193A1 (ru) 2-фенил-1-[4-(2-аминоэтокси)бензил]индол в комбинации с эстрогенами
ATE241994T1 (de) Hsv-mutant-1716 zur behandlung von mesotheliomen
ATE365206T1 (de) Verfahren zur entwicklung von einem hiv impfstoff
PT1242119E (pt) Combinacoes para o tratamento de infeccoes por virus adn incluindo um diuretico de ansa e um glicosido cardiotonico
ATE318893T1 (de) Verbesserte replikation von hcv rna
ATE206458T1 (de) T-zellen stimulierendes protein von pestivirus
ATE337309T1 (de) Pyranon- und pyrandioninhibitoren der rna- abhängigen rna-polymerase des hepatitis-c-virus
ATE479705T1 (de) Reduzierter slam abhängiger zell eintritt
NO985739D0 (no) Generering av molekyler som er replikative in vivo
ATE263234T1 (de) Veränderte, kleine rna-viren
DK0952982T3 (da) Hidtil ukendte hepatitis B inhibitorer
WO2003085084A3 (en) Hepatitis c virus sub-genomic replicons
EP1315794A4 (de) Genetische demonstrationder notwendigkeit von nkx6.1, nkx2.2 und nkx6.2 zur generierung von ventralen nervenzellen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1320583

Country of ref document: EP